Abstract:To protect our civilians and warfighters against both known and unknown pathogens, biodefense stakeholders must be able to foresee possible technological trends that could affect their threat risk assessment. However, significant flaws in how we prioritize our countermeasure-needs continue to limit their development. As recombinant biotechnology becomes increasingly simplified and inexpensive, small groups, and even individuals, can now achieve the design, synthesis, and production of pathogenic organisms for offensive purposes. Under these daunting circumstances, a reliable biosurveillance approach that supports a diversity of users could better provide early warnings about the emergence of new pathogens (both natural and manmade), reverse engineer pathogens carrying traits to avoid available countermeasures, and suggest the most appropriate detection, prophylactic, and therapeutic solutions. While impressive in data mining capabilities, real-time content analysis of social media data misses much of the complexity in the factual reality. Quality issues within freeform user-provided hashtags and biased referencing can significantly undermine our confidence in the information obtained to make critical decisions about the natural vs. intentional emergence of a pathogen. At the same time, errors in pathogen genomic records, the narrow scope of most databases, and the lack of standards and interoperability across different detection and diagnostic devices, continue to restrict the multidimensional biothreat assessment. The fragmentation of our biosurveillance efforts into different approaches has stultified attempts to implement any new foundational enterprise that is more reliable, more realistic and that avoids the scenario of the warning that comes too late. This discussion focus on the development of genomic-based decentralized medical intelligence and laboratory system to track emerging and novel microbial health threats in both military and civilian settings and the use of virulence factors for risk assessment. Examples of the use of motif fingerprints for pathogen discrimination are provided.

A bumpy road ahead for genetic biocontainment

Biocontainment of genetically modified organisms by synthetic protein design

Research Progress in Biocontainment of Genetically Modified Organisms

Xenobiology for the Biocontainment of Synthetic Organisms: Opportunities and Challenges

Points to consider in seeking biosafety approval for research, testing, and environmental release of experimental genetically modified biocontrol products during research and development

Transgene containment by molecular means--is it possible and cost effective?

Engineering stringent genetic biocontainment of yeast with a protein stability switch

Revolution versus evolution?: Understanding scientific and technological diffusion in synthetic biology and their implications for biosecurity policies

Advances on transgene containment technologies]

Biosecurity Assessments for Emerging Transdisciplinary Biotechnologies: Revisiting Biodefense in an Age of Synthetic Biology

Biosecurity: Progress and Challenges

Cyber-biological convergence: a systematic review and future outlook

Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements

The bioterrorism threat and dual-use biotechnological research: an Israeli perspective

Bioinformatics for Biodefense: Challenges and Opportunities

Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward

Deployment of Engineered Microbes: Contributions to the Bioeconomy and Considerations for Biosecurity

Biosurveillance enterprise for operational awareness, a genomic-based approach for tracking pathogen virulence

Challenges and recent progress in the governance of biosecurity risks in the era of synthetic biology

Biosafety and biosecurity in Synthetic Biology: A review

Towards Responsible Governance of Biological Design Tools